JPS5315411A - Improvent concerning to organic compound - Google Patents

Improvent concerning to organic compound

Info

Publication number
JPS5315411A
JPS5315411A JP8887677A JP8887677A JPS5315411A JP S5315411 A JPS5315411 A JP S5315411A JP 8887677 A JP8887677 A JP 8887677A JP 8887677 A JP8887677 A JP 8887677A JP S5315411 A JPS5315411 A JP S5315411A
Authority
JP
Japan
Prior art keywords
improvent
concerning
organic compound
isopropylamino
admixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8887677A
Other languages
English (en)
Other versions
JPS5726650B2 (ja
Inventor
Dragan Hazler
John Arthur Hersey
Jean-Pierre Nougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5315411A publication Critical patent/JPS5315411A/ja
Publication of JPS5726650B2 publication Critical patent/JPS5726650B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP8887677A 1976-07-27 1977-07-26 Improvent concerning to organic compound Granted JPS5315411A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (2)

Publication Number Publication Date
JPS5315411A true JPS5315411A (en) 1978-02-13
JPS5726650B2 JPS5726650B2 (ja) 1982-06-05

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8887677A Granted JPS5315411A (en) 1976-07-27 1977-07-26 Improvent concerning to organic compound

Country Status (27)

Country Link
JP (1) JPS5315411A (ja)
AR (1) AR216479A1 (ja)
AT (1) AT369987B (ja)
AU (1) AU515738B2 (ja)
BE (1) BE857122A (ja)
CA (1) CA1095833A (ja)
CY (1) CY1261A (ja)
DE (1) DE2732335C2 (ja)
DK (1) DK325677A (ja)
ES (1) ES461020A1 (ja)
FI (1) FI772217A (ja)
FR (1) FR2359607A1 (ja)
GB (1) GB1589982A (ja)
GR (1) GR65014B (ja)
HK (1) HK81884A (ja)
HU (1) HU178340B (ja)
IE (1) IE45534B1 (ja)
IL (1) IL52587A (ja)
KE (1) KE3441A (ja)
MY (1) MY8400057A (ja)
NL (1) NL176227C (ja)
NO (1) NO149874C (ja)
NZ (1) NZ184722A (ja)
PT (1) PT66850B (ja)
SE (1) SE437469B (ja)
SG (1) SG53884G (ja)
ZA (1) ZA774536B (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
JP2010163450A (ja) * 2001-12-14 2010-07-29 Alexander Macgregor 作用剤の輸送の制御及び吸収の向上のための逆ミセル送達システム

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (ja) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
JPH0142924B2 (ja) * 1980-09-08 1989-09-18 Kyorin Seiyaku Kk
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
JP2010163450A (ja) * 2001-12-14 2010-07-29 Alexander Macgregor 作用剤の輸送の制御及び吸収の向上のための逆ミセル送達システム

Also Published As

Publication number Publication date
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
IL52587A0 (en) 1977-10-31
DE2732335C2 (de) 1983-01-20
NZ184722A (en) 1980-10-24
NL7708162A (nl) 1978-01-31
DK325677A (da) 1978-01-28
NL176227B (nl) 1984-10-16
DK325877A (da) 1978-01-20
MY8400057A (en) 1984-12-31
PT66850B (fr) 1979-03-13
NO772575L (no) 1978-01-30
SE7708265L (sv) 1978-01-28
NO149874B (no) 1984-04-02
GR65014B (en) 1980-06-13
HK81884A (en) 1984-11-25
ZA774536B (en) 1979-02-28
NL176227C (nl) 1985-03-18
PT66850A (fr) 1977-08-01
SE437469B (sv) 1985-03-04
IE45534B1 (en) 1982-09-22
JPS5726650B2 (ja) 1982-06-05
FR2359607A1 (fr) 1978-02-24
AR216479A1 (es) 1979-12-28
DE2732335A1 (de) 1978-02-02
ATA541377A (de) 1982-07-15
BE857122A (fr) 1978-01-25
SG53884G (en) 1985-03-08
IL52587A (en) 1980-09-16
FR2359607B1 (ja) 1980-02-22
CY1261A (en) 1984-11-23
KE3441A (en) 1984-09-14
GB1589982A (en) 1981-05-20
CA1095833A (en) 1981-02-17
NO149874C (no) 1984-07-11
ES461020A1 (es) 1979-05-01
FI772217A (ja) 1978-01-28
AU515738B2 (en) 1981-04-30
AT369987B (de) 1983-02-25
AU2730177A (en) 1979-02-01

Similar Documents

Publication Publication Date Title
IT1058156B (it) Composto ignifugo e procedimento per la sua preparazione
NO154403C (no) Tetningskule for stengning av perforeringer i et foringsroer.
IT7883451A0 (it) Fune d' acciaio-alluminio particolarmente idonea per la conduzione di elettricita' eprocedimento per la produzione ditale fune.
NL184722B (nl) Meercomponentencapsule voor tandtechnische doeleinden.
NO158526C (no) Sammensatt gass- og damptett folie for emballeringsformaal.
JPS5315411A (en) Improvent concerning to organic compound
FR2275210B1 (ja)
NO791205L (no) 2-(2-tenoyltio)-propionylglycin, fremgangsmaate for fremstilling derav og farmasoeytiske formuleringer som inneholder forbindelsen
NL190662C (nl) alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat.
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
FR2299045A1 (fr) Elements d'etancheite ignifugeants
DK240979A (da) 3-azabicyclo (3,1,0) hexanderivater
GB2031074B (en) High-temperature seal
NL7902467A (nl) Brandvrije kast.
DK158489C (da) Fremgangsmaade til fremstilling af et acesulfamholdigt praeparat
DK96579A (da) 1-oxo-1h-pyrimido (6,1-b) benzthiazolderivater og fremgangsmaade til deres fremstilling
ES485168A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica util para el tratamiento de la hipercolesteremia.
IT7821727A0 (it) 3-ammino-1-sostituito-1, 2,4-benzotiadiazin-1-ossido, utile quale agente ipotensivo, eprocedimento per la sua preparazione.
TR20207A (tr) Substituee alkanil-azolil aksim-karbamatlar,imallerine mahsus usuler ve ensektisidler,akarisidler ve nematosidler olarak kullanilmalari
NZ186310A (en) Derivatives of 5-(1-hydroxy-2-aminoethyl)-benzenesulphonamide or -benzamide, and pharmaceutical compositions
NO793164L (no) Fremgangsmaate for fremstilling av natriumamoksycillan
SE7603223L (sv) 13,14-dehydro-11-deoxi-prostaglandiner och forfarande for deras framstellning
FI55609B (fi) Foerfarande foer framstaellning av farmaceutiska kompositioner innehaollande 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxi-4,16,32,34,36-pentametyltetrakonta-16,32-dien-35-0-lakton-40-guanidiniumsulfat (debrycin)
SE8204871L (sv) Farmaceutiska preparat, innefattande humant proinsulin
NL7902468A (nl) Brandvrije kast.